Patrick Michael Monahan, MD
Specialist · Campbell
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 24
- 5 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
24 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Monahan’s office at (408) 559-0666 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G60723 · Current
Licensed to practise in California · since 1987 · expires 2027-06-30 · University of Virginia School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$17,647 in 2022
Medicaid paid $17,647 for 579 billed services this clinician did in 2022, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Intravitreal injection of a pharmacologic agent (separate procedure) | 112 | $7,647 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 91 | $3,383 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 266 | $3,357 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 110 | $3,259 |
| 2022 | 579 | 4 | 30 | $17,647 |
| 2021 | 474 | 5 | 24 | $11,430 |
| 2020 | 460 | 5 | 31 | $14,233 |
| 2019 | 748 | 5 | 41 | $20,367 |
| 2018 | 557 | 5 | 36 | $17,708 |
See the largest Medicaid services in earlier years
2021
| Intravitreal injection of a pharmacologic agent (separate procedure) | 69 | $4,109 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 229 | $2,759 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 82 | $2,328 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 66 | $1,589 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 28 | $645 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 145 | $5,318 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 80 | $4,423 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 207 | $3,570 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $588 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 16 | $335 |
2019
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 220 | $6,704 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 82 | $5,779 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 349 | $4,417 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 68 | $2,343 |
| Injection, bevacizumab, 10 mg | 29 | $1,125 |
2018
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 130 | $5,788 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 297 | $5,506 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 85 | $3,445 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 30 | $2,318 |
| Injection, bevacizumab, 10 mg | 15 | $652 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 112 Part D prescriptions in 2022.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 112 | 72 | 0% (0) | 40% | $8,656 |
| 2021 | 119 | 67 | 0% (0) | 57% | $9,842 |
| 2020 | 96 | 57 | 0% (0) | 73% | $8,845 |
| 2019 | 161 | 87 | 0% (0) | 64% | $16,277 |
| 2018 | 184 | 91 | None | 73% | $14,289 |
| 2017 | 172 | 84 | None | 73% | $16,032 |
| 2016 | 218 | 82 | 0% (0) | 66% | $22,403 |
| 2015 | 222 | 74 | None | 68% | $24,114 |
| 2014 | 210 | 69 | 0% (0) | 62% | $20,574 |
| 2013 | 229 | 78 | None | 62% | $19,173 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Tobramycin-Dexamethasone | 53 | $3,909 | $74 |
| Prednisolone Acetate | 31 | $1,963 | $63 |
2021: 2 drugs
| Prednisolone Acetate | 46 | $2,852 | $62 |
| Tobramycin-Dexamethasone | 38 | $2,840 | $75 |
2020: 2 drugs
| Prednisolone Acetate | 43 | $2,794 | $65 |
| Tobramycin-Dexamethasone | 32 | $2,782 | $87 |
2019: 3 drugs
| Tobramycin-Dexamethasone | 67 | $5,781 | $86 |
| Lotemax | 20 | $4,805 | $240 |
| Prednisolone Acetate | 54 | $3,325 | $62 |
2018: 2 drugs
| Prednisolone Acetate | 99 | $6,781 | $68 |
| Tobramycin-Dexamethasone | 52 | $4,310 | $83 |
2017: 3 drugs
| Prednisolone Acetate | 80 | $5,491 | $69 |
| Tobramycin-Dexamethasone | 50 | $4,794 | $96 |
| Lotemax | 14 | $2,483 | $177 |
2016: 4 drugs
| Tobramycin-Dexamethasone | 65 | $8,808 | $136 |
| Brimonidine | 52 | $5,451 | $105 |
| Prednisolone Acetate | 42 | $2,754 | $66 |
| Lotemax | 11 | $2,117 | $192 |
2015: 5 drugs
| Tobramycin-Dexamethasone | 67 | $9,692 | $145 |
| Brimonidine | 59 | $6,857 | $116 |
| Prednisolone Acetate | 41 | $2,782 | $68 |
| Lotemax | 14 | $2,606 | $186 |
| Atropine Sulfate | 12 | $259 | $22 |
2014: 4 drugs
| Tobramycin-Dexamethasone | 65 | $9,263 | $143 |
| Brimonidine | 63 | $7,212 | $114 |
| Prednisolone Acetate | 36 | $2,669 | $74 |
| Atropine Sulfate | 21 | $380 | $18 |
2013: 5 drugs
| Tobramycin-Dexamethasone | 64 | $10,423 | $163 |
| Brimonidine | 56 | $4,940 | $88 |
| Prednisolone Acetate | 37 | $770 | $21 |
| Atropine Sulfate | 19 | $356 | $19 |
| Latanoprost | 13 | $291 | $22 |
Money from drug and device companies
$24 in 2022
| 2022 | 1 | 1 | None | $24 |
| 2020 | 2 | 3 | None | $59 |
| 2019 | 3 | 3 | None | $53 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech USA | Vabysmo | $24 | 1 payment
|
See the published payment
| Genentech USA | Meals · 2022-02-09 | Vabysmo | $24 |
See earlier years (2020, 2019)
2020: $59
| Optos | P200dtx | $39 | 2 payments
|
| Regeneron Healthcare Solutions | Eylea | $21 | 1 payment
|
2019: $53
| Novartis Pharmaceuticals | None | $20 | 1 payment
|
| Optos | P200dtx | $20 | 1 payment
|
| Genentech USA | Lucentis | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1891783148
- Licence
- CA G60723California G60723: Current · expires 2027-06-30
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G607230
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 3395 S Bascom Ave Ste 140, Campbell, CA, 95008
- NPI first listed
- 2005-10-11
- NPI last updated
- 2015-08-11
This is when the NPI record was last certified, not a medical board exam.